Clinical Trials Browser

OTHER × Neuroblastoma × Ketoconazole × Clear all

NCT00295919 2023-04-07

N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma

Phase 1 Completed

Neuroblastoma